From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4)
- 1 January 2021
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 210, 112963
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Deutsche Forschungsgemeinschaft (EXC 2180–390900677)
This publication has 19 references indexed in Scilit:
- BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signalingeLife, 2013
- A Therapy for Liver Failure Found in the JNK YardCell, 2013
- A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver RegenerationCell, 2013
- MAP Kinase PathwaysCold Spring Harbor Perspectives in Biology, 2012
- Design, Synthesis, and Biological Evaluation of 3-(1H-1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonine315→Isoleucine315 MutantJournal of Medicinal Chemistry, 2012
- Rapid, microwave-assisted organic synthesis of selective V600EBRAF inhibitors for preclinical cancer researchTetrahedron Letters, 2012
- Pyrazolopyridine Inhibitors of B-RafV600E. Part 1: The Development of Selective, Orally Bioavailable, and Efficacious InhibitorsACS Medicinal Chemistry Letters, 2011
- Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics, 2008
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- A small molecule–kinase interaction map for clinical kinase inhibitorsNature Biotechnology, 2005